Analysts See $0.01 EPS for Pharma-Bio Serv, Inc. (PBSV)

September 8, 2018 - By Jack Shaw

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Logo

Analysts expect Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) to report $0.01 EPS on September, 13.They anticipate $0.02 EPS change or 200.00 % from last quarter’s $-0.01 EPS. PBSV’s profit would be $230,619 giving it 15.75 P/E if the $0.01 EPS is correct. After having $-0.01 EPS previously, Pharma-Bio Serv, Inc.’s analysts see -200.00 % EPS growth. It closed at $0.63 lastly. It is down 0.00% since September 8, 2017 and is . It has underperformed by 12.57% the S&P500.

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil. The company has market cap of $14.53 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. It currently has negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.